Autophagy inhibition by sustained overproduction of IL6 contributes to arsenic carcinogenesis.
Autophagy inhibition by sustained overproduction of IL6 contributes to arsenic carcinogenesis.
复制标题
DOI:
10.1158/0008-5472.can-13-3182
复制
发表时间:
2014-07-15
期刊:
影响因子:
11.2
通讯作者:
Chen G
中科院分区:
文献类型:
--
作者:
Qi Y;Zhang M;Li H;Frank JA;Dai L;Liu H;Zhang Z;Wang C;Chen G
Chronic inflammation has been implicated as an etiological factor in cancer, whereas autophagy may help preserve cancer cell survival but exert anti-inflammatory effects. How these phenomena interact during carcinogenesis remains unclear. We explored this question in a human bronchial epithelial cell-based model of lung carcinogenesis that is mediated by sub-chronic exposure to arsenic. We found that sustained overexpression of the pro-inflammatory interleukin IL-6 promoted arsenic-induced cell transformation by inhibiting autophagy. Conversely, strategies to enhance autophagy counteracted the effect of IL-6 in the model. These findings were confirmed and extended in a mouse model of arsenic-induced lung cancer. Mechanistic investigations suggested that mTOR inhibition contributed to the activation of autophagy, whereas IL-6 overexpression was sufficient to block autophagy by supporting Beclin-1/Mcl-1 interaction. Overall, our findings argued that chronic inflammatory states driven by IL-6 could antagonize autophagic states that may help preserve cancer cell survival and promote malignant progression, suggesting a need to uncouple inflammation and autophagy controls to enable tumor progression.